Home › Funds › Maverick Capital › MANE
Maverick Capital position in MANE
VERADERMICS · Health Care
Maverick Capital reported holding 941,846 shares of MANE (VERADERMICS) in its Q3 2026 13F filing — a position valued at US$114.2M, representing 0.93% of its reported portfolio and ranking #31 among its reported holdings. Maverick Capital has disclosed MANE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How Maverick Capital's MANE position evolved
Maverick Capital first disclosed a stake in MANE in Q2 2026 at 789,980 shares (US$97.1M). The position peaked in Q3 2026 at 941,846 shares, worth US$114.2M. Across 2 filings, Maverick Capital increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 941,846 shares valued at US$114.2M — an increase of 151,866 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 789.98K | $97.12M | New |
| Q3 2026 | 941.85K | $114.18M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MANE and 13F data
MANE (VERADERMICS) is a Health Care company. 128 other funds we track also report a position in MANE — the largest reported positions include MONTANOVA CAPITAL, LLC (US$450.9M), SR ONE CAPITAL MANAGEMENT, LP (US$252.2M), Deep Track Capital, LP (US$230.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MANE
- MONTANOVA CAPITAL, LLC 3.72M sh · $450.85M · Q3 2026
- SR ONE CAPITAL MANAGEMENT, LP 2.08M sh · $252.17M · Q3 2026
- Deep Track Capital, LP 1.90M sh · $230.34M · Q3 2026
- Siren, L.L.C. 1.32M sh · $160.54M · Q3 2026
- MAVERICK CAPITAL LTD 941.85K sh · $114.18M · Q3 2026
- INFINITUM ASSET MANAGEMENT, LLC 832.94K sh · $100.98M · Q3 2026
- EMERALD ADVISERS, LLC 332.39K sh · $40.30M · Q3 2026
- Paradigm Biocapital Advisors LP 310.06K sh · $37.59M · Q3 2026
- EMERALD MUTUAL FUND ADVISERS TRUST 225.55K sh · $27.34M · Q3 2026
- Logos Global Management LP 170.00K sh · $20.61M · Q3 2026
- Kalehua Capital Management LLC 145.69K sh · $17.66M · Q3 2026
- Sofinnova Investments, Inc. 144.05K sh · $17.46M · Q3 2026
More on Maverick Capital
FAQ
How long has Maverick Capital held MANE?
Maverick Capital has disclosed MANE holdings in 2 of the last 2 reported quarters, going back to Q2 2026.
What is Maverick Capital's current position in MANE?
As of Q3 2026, Maverick Capital holds 941.85K shares of MANE (VERADERMICS), valued at $114.18M, representing 0.93% of its reported portfolio and ranking #31.
Has Maverick Capital been buying or selling MANE?
In the latest 13F filing (Q3 2026), Maverick Capital increased its position in MANE. The position peaked in Q3 2026 at 941.85K shares.
Which other funds hold MANE?
Other major institutional holders of MANE include MONTANOVA CAPITAL, LLC, SR ONE CAPITAL MANAGEMENT, LP, Deep Track Capital, LP, among 128 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.